SecBot SecBot
S-1/A ·Filed Nov 5, 2026
LI

LIS

LIS Technologies Inc
NEUTRAL
Impact 5/10
Horizonweeks Processed16d 15h ago SEC0001493152-26-050287
IPO registration amendment
Actionable Insight • Neutral

Monitor the effectiveness date and final pricing of the IPO. Track progress on NRC license application (expected Q1 2027 submission) and Phase 1/2 CRISLA demonstration results. Cash runway is limited to early fiscal 2027 without additional financing.

DirectionNeutral
Confidencemedium
Horizonweeks

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

LIS Technologies filed Amendment No. 1 to its S-1 registration statement for an IPO of 3,100,000 shares (up from 2,833,334 in the prior filing) at an assumed price of $5.00-$7.00 per share, with net proceeds estimated at $16.6 million. The company is an early-stage uranium enrichment developer using the patented CRISLA laser process, has generated no revenue to date, and has an accumulated deficit of $65.4 million as of July 31, 2026. Proceeds will fund R&D, business development, and working capital.

Key Financial Metrics

Price Range
$5.00-$7.00 per share

Key Facts

  • IPO size increased to 3,100,000 shares from 2,833,334 shares in the prior S-1 filing
  • Assumed IPO price range $5.00-$7.00 per share, midpoint $6.00
  • Estimated net proceeds of $16.6 million (or $19.2 million with full over-allotment)
  • No revenue generated since inception; accumulated deficit of $65,418,743 as of July 31, 2026
  • Cash of $18.8 million as of July 31, 2026; cash burn $14.8 million in operating activities for nine months ended July 31, 2026
  • Technology at TRL 4 (laboratory validated); commercialization targeted for 2030-2033
  • DOE IDIQ contract participant; received $74,866 Air Force SBIR award
  • State of Tennessee incentives package valued at over $200 million (not yet received)
  • Related party NANO Nuclear invested $2 million; Joint Collaboration Agreement in place
  • CEO Jay Jiang Yu beneficially owns ~25.95% of shares pre-offering

Financial Impact

IPO net proceeds of $16.6 million; accumulated deficit of $65.4 million; cash burn $14.8 million in 9 months

cashaccumulated deficitdilution

Risk Factors

  • Pre-revenue, early-stage company with unproven technology at commercial scale
  • Requires substantial additional capital (estimated $1.38 billion for LEU-3 Facility)
  • NRC licensing process is complex, lengthy, and uncertain
  • Heavy reliance on related party NANO Nuclear for feedstock and collaboration
  • CEO has significant ownership and potential conflicts of interest with NANO Nuclear
  • No active trading market for shares; stock price may be volatile

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
S-1/A Filing (Primary)0001493152-26-050287
Exhibit: ex107.htm0001493152-26-050287
Exhibit: ex23-1.htm0001493152-26-050287
Document: 0001493152-26-050287-index-headers.html0001493152-26-050287
Document: 0001493152-26-050287-index.html0001493152-26-050287
Document: 0001493152-26-050287.txt0001493152-26-050287

Track record

2 reports on LIS

Performance horizon
Filters
  1. Nov 17, 20264d ago S-1/A Neutral 5/10 No price data
  2. Nov 5, 202616d ago S-1/A Neutral 5/10 Viewing No price data
Showing 2 of 2

US Market Status

Market Closed · Opens Mon (24h 45m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026